At Immumem Therapeutics Corp, we are dedicated to advancing the field of oncology through our best-in-class iPSC-derived cell therapy approach. Our mission is to harness the power of immunological memory to improve patient outcomes and revolutionize the treatment of refractory cancer types.
Combating cancer relapse through immunological memory
At Immumem Therapeutics Corp, our cutting-edge cell therapies are setting a new standard for cancer treatment through the development of next-generation iPSC-derived memory T and memory NK cell therapy products, aimed at improving accessibility, efficacy and combating cancer relapse.
For General Inquiries: contact@immumemtx.com
For Investment Inquiries: investments@immumemtx.com
